Corticosteroids vs steroids

The most common side effect of topical corticosteroid use is skin atrophy. All topical steroids can induce atrophy, but higher potency steroids, occlusion, thinner skin, and older patient age increase the risk. The face, the backs of the hands, and intertriginous areas are particularly susceptible. Resolution often occurs after discontinuing use of these agents, but it may take months. Concurrent use of topical tretinoin (Retin-A) % may reduce the incidence of atrophy from chronic steroid applications. 30 Other side effects from topical steroids include permanent dermal atrophy, telangiectasia, and striae.

Register for alerts
If you have registered for alerts, you should use your registered email address as your username

  • Citation tools Download this article to citation manager Sadeghirad Behnam , Siemieniuk Reed A C , Brignardello-Petersen Romina , Papola Davide , Lytvyn Lyubov , Vandvik Per Olav et al. Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials BMJ 2017; 358 :j3887
    • BibTeX (win & mac) Download
    • EndNote (tagged) Download
    • EndNote 8 (xml) Download
    • RefWorks Tagged (win & mac) Download
    • RIS (win only) Download
    • Medlars Download
    Help If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

    Kaposi's sarcoma has been reported to occur in patients receiving corticosteroid therapy. Discontinuation of corticosteroids may result in clinical remission.
    Although controlled clinical trials have shown corticosteroids to be effective in speeding the resolution of acute exacerbations of multiple sclerosis , they do not show that corticosteroids affect the ultimate outcome or natural history of the disease. The studies do show that relatively high doses of corticosteroids are necessary to demonstrate a significant effect. (See DOSAGE AND ADMINISTRATION .)

    Direct intravenous injection:
    Use only methylprednisolone sodium succinate.
    Reconstitute with provided diluent or add 2 ml of bacteriostatic water (with benzyl alcohol) for injection.
    May be administered undiluted.
    Administer directly into a vein over 3—15 minutes. Doses >= 2 mg/kg or 250 mg should be given by intermittent infusion (see below), unless the potential benefits of direct IV injection outweigh the potential risks (., life-threatening shock).
     
    Intermittent intravenous infusion:
    Use only methylprednisolone sodium succinate.
    Dilute in D5W, % Sodium Chloride (NS), or D5NS injection. Haze may form upon dilution.
    Infuse over 15—60 minutes. Large doses (., >= 500 mg) should be administered over at least 30—60 minutes.

    Register for alerts
    If you have registered for alerts, you should use your registered email address as your username

  • Citation tools Download this article to citation manager Aertgeerts Bert , Agoritsas Thomas , Siemieniuk Reed A C , Burgers Jako , Bekkering Geertruida E , Merglen Arnaud et al. Corticosteroids for sore throat: a clinical practice guideline BMJ 2017; 358 :j4090
    • BibTeX (win & mac) Download
    • EndNote (tagged) Download
    • EndNote 8 (xml) Download
    • RefWorks Tagged (win & mac) Download
    • RIS (win only) Download
    • Medlars Download
    Help If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

    Corticosteroids vs steroids

    corticosteroids vs steroids

    Direct intravenous injection:
    Use only methylprednisolone sodium succinate.
    Reconstitute with provided diluent or add 2 ml of bacteriostatic water (with benzyl alcohol) for injection.
    May be administered undiluted.
    Administer directly into a vein over 3—15 minutes. Doses >= 2 mg/kg or 250 mg should be given by intermittent infusion (see below), unless the potential benefits of direct IV injection outweigh the potential risks (., life-threatening shock).
     
    Intermittent intravenous infusion:
    Use only methylprednisolone sodium succinate.
    Dilute in D5W, % Sodium Chloride (NS), or D5NS injection. Haze may form upon dilution.
    Infuse over 15—60 minutes. Large doses (., >= 500 mg) should be administered over at least 30—60 minutes.

    Media:

    corticosteroids vs steroidscorticosteroids vs steroidscorticosteroids vs steroidscorticosteroids vs steroidscorticosteroids vs steroids

  • http://buy-steroids.org